Barbell Medicine Podcast

Direct Line April 2026: Stopping Ozempic and Lifting With Osteopenia

12 snips
Apr 21, 2026
They unpack what happens when people stop GLP-1 medications and why most weight and metabolic gains drift back toward baseline. They compare drug durability to lifestyle-only trials and argue the benefits accumulate only while the drug is taken. They also cover lifting with osteopenia, practical strength protocols, and evidence from the LIFTMOR high-intensity training study.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Two Thirds Of GLP-1 Weight Loss Returns Within A Year

  • GLP-1 weight loss is largely reversed after stopping with about two-thirds regained within a year on average.
  • SURMOUNT-4 and STEP trials show similar patterns: large initial loss on tirzepatide/semaglutide, then ~66% regain in ~12 months after cessation.
INSIGHT

GLP-1 Regain Is Faster Because Initial Losses Are Larger

  • Regain appears faster numerically after GLP-1 cessation compared to lifestyle-only, but that's because medications produced much larger initial losses.
  • When normalized to percent lost, regain trajectories are similar between GLP-1s and intensive lifestyle interventions.
ADVICE

Set Realistic Expectations Before Starting A GLP-1

  • Discuss GLP-1s as likely long-term tools for many patients and set expectation that ongoing therapy or maintenance strategies are common.
  • Emphasize building lifestyle habits while on therapy and individualizing plans for dose changes or tapering.
Get the Snipd Podcast app to discover more snips from this episode
Get the app